3 Reasons Amazing Isn't Good Enough For This Biotech Stock

Experimental treatments that use the body's own immune system to fight cancer are nothing short of amazing. At the year's biggest scientific conference for cancer drug developers, bluebird bio (NASDAQ: BLUE) showed us that its candidate can prolong the lives of people who had exhausted all available options.Despite the highly positive results released after the bell on Friday, the stock ticked up just a few percentage points on Monday.

Topics:  blue    images   amazing   stock   cancer   bluebird   bio   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News